Lithium chloride reduced the level of oxidative stress in brains and serums of APP/PS1 double transgenic mice via the regulation of GSK3β/Nrf2/HO-1 pathway

References

• Hardy J, Selkoe DJ. The amyloid hypothesis of Alzheimer’s disease: progress and problems on the road to therapeutics. Science. 2002;297(5580):353–356.
   PubMed Web of Science ®Google Scholar
• Haass C, Selkoe DJ. Cellular processing of beta-amyloid precursor protein and the genesis of amyloid beta-peptide. Cell. 1993;75(6):1039–1042.
   PubMed Web of Science ®Google Scholar
• Wang W, Wu Y, Zhang G, et al. Activation of Nrf2-ARE signal pathway protects the brain from damage induced by epileptic seizure. Brain Res. 2014;1544:54–61.
   PubMed Web of Science ®Google Scholar
• Dong YT, Cao K, Tan LC, et al. Stimulation of SIRT1 attenuates the level of oxidative stress in the brains of APP/PS1 double transgenic mice and in primary neurons exposed to oligomers of the Amyloid-β peptide. J Alzheimers Dis. 2018;63(1):283–301.
   PubMed Web of Science ®Google Scholar
• Llorach-Pares L, Nonell-Canals A, Avila C, et al. Kororamides, convolutamines, and indole derivatives as possible tau and dual-specificity kinase inhibitors for Alzheimer’s disease: a computational study. Mar Drugs. 2018;16(10):386.
   Web of Science ®Google Scholar
• Kim K, Cha JS, Kim JS, et al. Crystal structure of GSK3β in complex with the flavonoid, morin. Biochem Biophys Res Commun. 2018;504(2):519–524.
   PubMed Web of Science ®Google Scholar
• Cai L, Li Y, Zhang Q, et al. Salidroside protects rat liver against ischemia/reperfusion injury by regulating the GSK-3β/Nrf2-dependent antioxidant response and mitochondrial permeability transition. Eur J Pharmacol. 2017;806:32–42.
   PubMed Web of Science ®Google Scholar
• Rojo AI, Pajares M, Rada P, et al. Nrf2 deficiency replicates transcriptomic changes in Alzheimer’s patients and worsens APP and TAU pathology. Redox Biol. 2017;13:444–451.
   PubMed Web of Science ®Google Scholar
• Zhao F, Zhang J, Chang N. Epigenetic modification of Nrf2 by sulforaphane increases the antioxidative and anti-inflammatory capacity in a cellular model of Alzheimer’s disease. Eur J Pharmacol. 2018;824:1–10.
   PubMed Web of Science ®Google Scholar
• Li C, Wang R, Hu C, et al. Pyridoxine exerts antioxidant effects in cell model of Alzheimer’s disease via the Nrf-2/HO-1 pathway. Cell Mol Biol (Noisy-le-grand). 2018;64(10):119–124.
   PubMed Web of Science ®Google Scholar
• Berk C, Paul G, Sabbagh M. Investigational drugs in Alzheimer’s disease: current progress. Expert Opin Investig Drugs. 2014;23(6):837–846.
   PubMed Web of Science ®Google Scholar
• Cummings J, Lee G, Mortsdorf T, et al. Alzheimer’s disease drug development pipeline: 2017. Alzheimers Dement (NY). 2017;3:367–384.
   PubMedGoogle Scholar
• Sharma A, Pachauri V, Flora S. Advances in multi-functional ligands and the need for metal-related pharmacology for the management of Alzheimer disease. Front Pharmacol. 2018;9(1247).
   Google Scholar
• Nunes PV, Forlenza OV, Gattaz WF. Lithium and risk for Alzheimer’s disease in elderly patients with bipolar disorder. Br J Psychiatry. 2007;190(4):359–360.
   PubMed Web of Science ®Google Scholar
• Sofola-Adesakin O, Castillo-Quan JI, Rallis C, et al. Lithium suppresses Aβ pathology by inhibiting translation in an adult drosophila model of Alzheimer’s disease. Front Aging Neurosci. 2014; 6(190).
   PubMed Web of Science ®Google Scholar
• Rockenstein E, Torrance M, Adame A, et al. Neuroprotective effects of regulators of the glycogen synthase kinase-3beta signaling pathway in a transgenic model of Alzheimer’s disease are associated with reduced amyloid precursor protein phosphorylation. J Neurosci. 2007;27(8):1981–1991.
   PubMed Web of Science ®Google Scholar
• Zhao L, Gong N, Liu M, et al. Beneficial synergistic effects of microdose lithium with pyrroloquinolinequinone in an Alzheimer’s disease mouse model. Neurobiol Aging. 2014;35(12):2736–2745.
   PubMed Web of Science ®Google Scholar
• Choi SH, Kim YH, Hebisch M, et al. A three-dimensional human neural cell culture model of Alzheimer’s disease. Nature. 2014;515(7526):274–278.
   PubMed Web of Science ®Google Scholar
• Tian Y, Wang W, Xu L, et al. Activation of Nrf2/ARE pathway alleviates the cognitive deficits in PS1V97L-Tg mouse model of Alzheimer’s disease through modulation of oxidative stress. J Neurosci Res. 2019;97(4):492–505.
   PubMed Web of Science ®Google Scholar
• Delibas N, Ozcankaya R, Altuntas I. Clinical importance of erythrocyte malondialdehyde levels as a marker for cognitive deterioration in patients with dementia of Alzheimer type: a repeated study in 5-year interval. Clin Biochem. 2002;35(2):137–141.
   PubMed Web of Science ®Google Scholar
• Ali T, Kim T, Rehman SU, et al. Natural dietary supplementation of anthocyanins via PI3K/Akt/Nrf2/HO-1 pathways mitigate oxidative stress, neurodegeneration, and memory impairment in a mouse model of Alzheimer’s disease. Mol Neurobiol. 2018;55(7):6076–6093.
   PubMed Web of Science ®Google Scholar
• Farr SA, Sandoval KE, Niehoff ML, et al. Peripheral administration of GSK-3β antisense aligonucleotide improves learning and memory in SAMP8 and Tg2576 mouse models of Alzheimer’s disease. J Alzheimers Dis. 2016;54(4):1339–1348.
   PubMed Web of Science ®Google Scholar
• Chen JF, Long ZM, Li YZ, et al. Alteration of the Wnt/GSK3β/β-catenin signalling pathway by rapamycin ameliorates pathology in an Alzheimer’s disease model. Int J Mol Med. 2019;44:313–323.
   PubMed Web of Science ®Google Scholar
• Cao HM, Gang YU. The research Progress of Nrf2 in Alzheimer’s disease. Prog Biochem Biophys. 2015;42:533–539.
   Web of Science ®Google Scholar
• Kerr F, Bjedov I, Sofola-Adesakin O. Molecular mechanisms of lithium action: switching the light on multiple targets for dementia using animal models. Front Mol Neurosci. 2018;11:297.
   PubMed Web of Science ®Google Scholar
• Rojo AI, Rada P, Egea J, et al. Functional interference between glycogen synthase kinase-3 beta and the transcription factor Nrf2 in protection against kainate-induced hippocampal cell death. Mol Cell Neurosci. 2008;39(1):125–132.
   PubMed Web of Science ®Google Scholar
• Morris G, Berk M. The putative use of lithium in Alzheimer’s disease. Curr Alzheimer Res. 2016;13(8):853–861.
   PubMed Web of Science ®Google Scholar
• de Sousa RT, Zanetti MV, Talib LL, et al. Lithium increases platelet serine-9 phosphorylated GSK-3β levels in drug-free bipolar disorder during depressive episodes. J Psychiatr Res. 2015;62:78–83.
   PubMed Web of Science ®Google Scholar
• Pérez-Sen R, Queipo MJ, Morente V, et al. Neuroprotection mediated by P2Y13 nucleotide receptors in neurons. Comput Struct Biotechnol J. 2015;13:160–168.
   PubMed Web of Science ®Google Scholar
• Gawlik-Kotelnicka O, Mielicki W, Rabe-Jabłońska J, et al. Impact of lithium alone or in combination with haloperidol on oxidative stress parameters and cell viability in SH-SY5Y cell culture. Acta Neuropsychiatr. 2016;28(1):38–44.
   PubMed Web of Science ®Google Scholar
• Nciri R, Desmoulin F, Allagui MS, et al. Neuroprotective effects of chronic exposure of SH-SY5Y to low lithium concentration involve glycolysis stimulation, extracellular pyruvate accumulation and resistance to oxidative stress. Int J Neuropsychopharmacol. 2013;16(2):365–376.
   PubMed Web of Science ®Google Scholar
• Allagui MS, Nciri R, Rouhaud MF, et al. Long-term exposure to low lithium concentrations stimulates proliferation, modifies stress protein expression pattern and enhances resistance to oxidative stress in SH-SY5Y cells. Neurochem Res. 2009;34(3):453–462.
   PubMed Web of Science ®Google Scholar
• Aminzadeh A, Dehpour AR, Safa M, et al. Investigating the protective effect of lithium against high glucose-induced neurotoxicity in PC12 cells: involvements of ROS, JNK and P38 MAPKs, and apoptotic mitochondria pathway. Cell Mol Neurobiol. 2014;34(8):1143–1150.
   PubMed Web of Science ®Google Scholar
• Correa F, Mallard C, Nilsson M, et al. Activated microglia decrease histone acetylation and Nrf2-inducible anti-oxidant defence in astrocytes: restoring effects of inhibitors of HDACs, p38 MAPK and GSK3β. Neurobiol Dis. 2011;44(1):142–151.
   PubMed Web of Science ®Google Scholar
• Loboda A, Damulewicz M, Pyza E, et al. Role of Nrf2/HO-1 system in development, oxidative stress response and diseases: an evolutionarily conserved mechanism. Cell Mol Life Sci. 2016;73(17):3221–3247.
   PubMed Web of Science ®Google Scholar
• Mathur A, Pandey VK, Kakkar P. Activation of GSK3β/β-TrCP axis via PHLPP1 exacerbates Nrf2 degradation leading to impairment in cell survival pathway during diabetic nephropathy. Free Radic Biol Med. 2018;120:414–424.
   PubMed Web of Science ®Google Scholar
• Han Y, Nan S, Fan J, et al. Inonotus obliquus polysaccharides protect against Alzheimer’s disease by regulating Nrf2 signaling and exerting antioxidative and antiapoptotic effects. Int J Biol Macromol. 2019;131:769–778.
   PubMed Web of Science ®Google Scholar
• Yu H, Yuan B, Chu Q, et al. Protective roles of isoastilbin against Alzheimer’s disease via Nrf2 mediated antioxidation and anti apoptosis. Int J Mol Med. 2019;43:1406–1416.
   PubMed Web of Science ®Google Scholar
• Jiao W, Wang Y, Kong L, et al. CART peptide activates the Nrf2/HO-1 antioxidant pathway and protects hippocampal neurons in a rat model of Alzheimer’s disease. Biochem Biophys Res Commun. 2018;501(4):1016–1022.
   PubMed Web of Science ®Google Scholar
• Shen X, Hu B, Xu G, et al. Activation of Nrf2/HO-1 pathway by glycogen synthase kinase-3β inhibition attenuates renal ischemia/reperfusion injury in diabetic rats. Kidney Blood Press Res. 2017;42(2):369–378.
   PubMed Web of Science ®Google Scholar
• Won E, Kim YK. An oldie but goodie: lithium in the treatment of bipolar disorder through neuroprotective and neurotrophic mechanisms. Int J Mol Sci. 2017;18(12):2679.
   Web of Science ®Google Scholar